Home > NRC Library > ADAMS Public Documents
Amend 3 to License 40-16775-01 for Prairie Lakes Health Care Sys,Inc,authorizing use of byproduct matls identified in 10CFR35.100,35.200,35.300,35.400 & 35.500 for medical use & in 10CFR31.11 for in vitro studies.
Accession Number: ML20238D574
Date Released: Thursday, October 24, 2024
Package Contents
The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.
- ML20238D731 - Responds to NRC questions re application for renewal of License 40-16775-01.Training & experience of RN Crank encl. Purchase of bone mineral analyzer BMA on hold. (4 page(s), 3/25/1987)
- ML20238D791 - Requests addl info re application for renewal of License 40-16775-01,including detailed description of individual isotopes & amounts of each isotope that Crank has had experience w/during past 5 yrs. (3 page(s), 3/5/1987)
- ML20238D818 - Responds to NRC 861218 questions re application for renewal of License 40-16775-01.R Crank preceptor statement & educational outline for nuclear medicine technologists encl. TLD rings being used to monitor fingertip exposures. (29 page(s), 1/16/1987)
- ML20238D843 - Requests addl info re application for renewal of License 40-16775-01,including institution name,RN Crank background & isotopic experience & type of device used to monitor fingertip exposures. (4 page(s), 12/18/1986)
- ML20238D881 - Forwards application for license,authorizing use of Gd-153 for purchase of DPA for osteoporosis.Memorial Medical Ctr under License 40-16775-01 combined w/another hosp to form Prairie Lakes Hosp. (1 page(s), 10/31/1986)
- ML20238D900 - Application for license,authorizing BJ Desai,RJ Meyer & R Crank to use matls listed in 10CFR31.11 & 10CFR35.100 & 10 mCi I-131 for treatment of hyperthyroidism.Related documentation encl.Fee paid. (25 page(s), 10/31/1986)
- ML20244B322 - Application for renewal of Matl/Byproduct License 40-16775-01 authorizing BJ Desai & RJ Meyer to use or supervise use of byproduct matl in Groups I-VI,10CFR31.11, I-131,P-32,Au-198 & Co-57 for medical use. (30 page(s), 1/20/1981)
- ML20238D921 - Requests new editions of 10CFR19,20,25,30,71 & 170. (1 page(s), 10/3/1980)
- ML20244B181 - Application for renewal of Matl/Byproduct License 40-16775-01 authorizing I-125 & I-131 as iodide & labeled human serum albumin for thyroid function studies & determination of blood & blood plasma vol,respectively. (4 page(s), 9/15/1980)
- ML20238D957 - Requests payment of addl fee for application for new matl license,per 10CFR170.31. (1 page(s), 11/7/1986)